№ lp_1_2_03918
File format: docx
Character count: 38481
File size: 342 KB
This document outlines an evaluation plan for assessing the Georgia Breast and Cervical Cancer Program (GBCCP), focusing on performance, program implementation, and effectiveness in preventing and addressing breast and cervical cancers among women in Georgia.
Year:
2017
Region / City:
Georgia
Subject:
Cancer prevention, screening, and healthcare services
Document Type:
Evaluation Plan
Organization:
Georgia Department of Public Health
Author:
Janet Y Shin, Kia Powell-Threets
Target Audience:
Health professionals, stakeholders involved in cancer prevention and treatment
Period of validity:
6/30/2017 – 6/29/2022
Approval Date:
1/31/2018
Amendment Date:
5/15/2018
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / city:
England
Theme:
Cervical screening, public health
Document type:
Letter
Organization / institution:
NHS England
Author:
Dr Amanda Doyle
Target audience:
Primary care practitioners, NHS staff, healthcare providers
Period of validity:
From 1 July 2025
Approval date:
11 June 2025
Date of changes:
1 July 2025
Year:
Not specified
Region / City:
Not specified
Theme:
Radiology, CT scans
Document Type:
Medical report
Organization / Institution:
Not specified
Author:
Dr. Vilayat Ali, Dr. Sandeep Agarwal, Dr. Annie Agarwal, Dr. Shivani Agarwal
Target Audience:
Healthcare professionals, Radiologists
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
United Kingdom
Topic:
Healthcare, Cervical Screening
Document Type:
Business Rules
Organization:
NHS England
Author:
General Practice Specification and Extraction Service (GPSES)
Target Audience:
GPES users, GP system suppliers
Period of validity:
2023-2024
Approval Date:
01/04/2023
Amendment Date:
01/04/2024
Contextual description:
Business rules and dataset specifications for cervical screening within the Quality and Outcomes Framework (QOF), created by NHS England for GPES use and GP system suppliers.
Note:
Year
Date:
1 November 2022
Last updated:
5 October 2022
Country:
Australia
Program:
National Cervical Screening Program (NCSP)
Legislative framework:
Health Insurance Act 1973
Issuing body:
Department of Health and Aged Care
Related organisations:
Cancer Council Australia; Royal Australian College of General Practitioners; Royal College of Pathologists of Australasia; Royal Australian and New Zealand College of Obstetricians and Gynaecologists; Australian Society for Colposcopy and Cervical Pathology; Australian Society of Gynaecologic Oncologists; Services Australia
Document type:
Policy update and schedule amendment notice
Subject:
Amendments to Medicare Benefits Schedule (MBS) items 73072 and 73074 and deletion of item 73073
Clinical category:
Support list (pathology)
Procedure type:
Type C
Affected services:
Oncogenic human papillomavirus (HPV) testing and cervical screening follow-up services
Target audience:
Healthcare professionals and pathology providers
Effective period:
From 1 November 2022
Year:
2025
Author:
John T. Salvucci
Email:
[email protected]
Type of document:
Case report
Topic:
Cervical manipulative therapy, vertebral artery dissection, ischemic stroke
Target audience:
Healthcare professionals, chiropractors, neurologists
Region:
United States
Data range:
Symptoms onset to stroke within 1–30 days
Institution:
Lewis Brisbois Bisgaard & Smith LLP
Year:
2022
Region / City:
Australia
Topic:
Health Policy
Document Type:
Policy Update
Organization:
National Cervical Screening Program (NCSP)
Author:
Medical Services Advisory Committee (MSAC)
Target Audience:
Healthcare professionals, healthcare providers, patients
Period of Effect:
From 1 July 2022
Approval Date:
21 June 2022
Changes Date:
March-April 2021
Changes Description:
Updates to Medicare Benefits Schedule (MBS) items 73071 and 73073
Context:
A policy update related to the expansion of self-collection for cervical screening under the NCSP, aimed at increasing access and participation in the program.
Year:
2009
Region / City:
Louisiana
Topic:
Medical Reporting, Cancer Diagnosis
Document Type:
Report
Institution:
Louisiana Tumor Registry
Author:
Not specified
Target Audience:
Healthcare providers, medical facilities, pathologists
Effective Period:
January 1, 2009 and after
Approval Date:
Not specified
Amendment Date:
January 1, 2019
Year:
2019
Month:
January
Organisation:
British Gynaecological Cancer Society (BGCS)
Region:
United Kingdom
Field:
Gynaecological Oncology
Topic:
Sentinel Lymph Node Technique in Vulval, Cervical and Endometrial Cancer
Document Type:
Consensus Statement
Authors:
Christina Fotopoulou; Thomas Ind; Peter Baldwin; Robin Crawford; Omer Devaja; Stephen Dobbs; Jonathan Frost; Ketan Gajjar; Raji Ganesan; Sonali Kaushik; Jo Morrison; Marielle Nobbenhuis; Nithya Ratnavelu; Phil Rolland; Naveena Singh; Alexandra Taylor; Sudha Sundar; Andy Nordin
Participating Body:
BGCS officers and expert members of the UK gynaecological oncological community
Methodology:
Delphi process with two rounds and 80% consensus threshold
Scope:
Applicability, oncologic safety and surgical safety of sentinel lymph node algorithms
Cancers Addressed:
Vulval cancer; Cervical cancer; Endometrial cancer
Guidelines Considered:
European Society of Gynaecological Oncologists (ESGO)
Implementation Context:
UK gynaecological cancer centres
Clinical Focus:
Surgical staging; SLN mapping; Lymphadenectomy; Histological ultra-staging; Training and audit requirements
Year:
2019
Region / City:
Christchurch, New Zealand
Topic:
Cervical Cancer, Screening History
Document Type:
Report
Organization:
University of Otago, Christchurch
Author:
Peter Sykes, Jonathan Williman, Carrie Innes, Phil Hider
Target Audience:
Health professionals, public health officials, researchers
Period of Validity:
2013-2017
Approval Date:
29 August 2019
Date of Amendments:
None
Keywords:
Cervical cancer, screening, incidence, age, ethnicity, rurality, deprivation, histology
Summary:
A report presenting a detailed review of cervical cancer occurrences in New Zealand between 2013 and 2017 in relation to screening history, including demographic factors and screening adequacy.
Program Name/Jurisdiction:
Maryland Breast and Cervical Cancer Program and/or CRF Cancer Prevention, Education, Screening and Treatment Program
Fiscal Year:
2024
Document Type:
Administrative standards and eligibility guidelines
Geographic Scope:
Maryland, United States
Administering Authority:
Local Maryland cancer screening programs
Subject:
Eligibility criteria for screening, diagnostic, referral, and treatment services
Target Population:
Maryland residents seeking cancer screening and related services
Eligibility Criteria:
Residency, annual gross household income up to 250% of Federal Poverty Level, family size, insurance status
Verification Requirements:
Verbal or written proof of residency, income documentation, insurance verification, Medicaid status confirmation via EVS
Programs Referenced:
BCCP-CPEST Programs, Patient Navigation Only (PNO), Cancer Screening and Tracking (CaST), Client Database (CDB)
Standards Referenced:
Minimal Clinical Elements (MCE), Minimal Standards for Nursing Case Management
Year:
2026
Region / City:
Tehran, Iran
Topic:
Cervical cancer screening and awareness
Document type:
Focus Group Discussion Questionnaire
Organization / Institution:
Not specified
Target audience:
Women in Tehran
Methodology:
Structured interviews
Health focus:
Prevention, detection, and treatment of cervical cancer
Key factors addressed:
Knowledge, perceptions, barriers, facilitators, participation plans
Year:
2020
Region / City:
Not specified
Theme:
Obstetrics, Labor Induction
Document Type:
Information Sheet
Institution:
Not specified
Author:
Not specified
Target Audience:
Pregnant individuals preparing for cervical ripening
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2015
Region / city:
Bangkok, Thailand; Nakhon Si Thammarat, Thailand
Topic:
Traumatic Spine Injury, Endotracheal Intubation
Document type:
Experimental research article
Institution:
Faculty of Medicine Ramathibodi Hospital, Mahidol University; Maharat Nakhon Si Thammarat Hospital
Authors:
Suttapanit Ka., Chuchan Y., Mankong Y., Yaemluksanalert N., Meesawad S., Jenpanitpong C., Watcharakitpaisan S.
Target audience:
Paramedics, Emergency medicine professionals
Methodology:
Manikin-based randomized study comparing intubation with and without cervical hard collar
Sample size:
126 paramedics
Ethics approval:
Institutional review board of Mahidol University (MURA2015/602)
Key variables:
Intubation success rate, time to successful intubation, use of cervical collar, manual stabilization
Year:
2017-2018
Region / City:
Doncaster
Subject:
Healthcare, Gynaecology
Document Type:
Service Specification
Organisation:
CCG
Author:
Not specified
Target Audience:
Healthcare Providers, GPs
Period of Validity:
1st April 2017 to 31st March 2018
Approval Date:
Not specified
Date of Review:
Annual
Date of Changes:
Not specified
Year:
2025
Region / City:
North West NHS GMS region
Topic:
ctDNA testing for NSCLC and breast cancer
Document Type:
Notification
Organization:
NHS England
Author:
Genomics Unit
Target Audience:
NHS Trusts
Period of Action:
2025/26 financial year
Approval Date:
7 November 2025
Date of Changes:
N/A
Context:
Notification regarding the continuation and expansion of ctDNA testing for lung and breast cancer in the North West NHS region for the 2025/26 financial year.
Year:
2024
Region / City:
International
Subject:
Nuclear medicine, breast cancer, estrogen receptor imaging
Document type:
Procedure standard / Practice guideline
Organization:
SNMMI, EANM
Authors:
David Mankoff, Sona Balogova, Lisa Dunnwald, Farrokh Dehdashti, Erik DeVries, Laura Evangelista, Michel Van Krutchen, Sofia Carriho Vaz, Amy Fowler, Hannah Linden, Gary Ulaner
Target audience:
Nuclear medicine practitioners, oncologists
Scope period:
Current clinical practice
Approval date:
2024
Revision cycle:
Every 5 years or sooner if indicated
Description:
Clinical guideline detailing standardized procedures for [18F]FES PET imaging of estrogen receptor expression in breast cancer patients, including methodology, interpretation, and quality assurance for diagnostic nuclear medicine.
Version:
4.4.0.0
Protocol Posting Date:
June 2021
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2022
Authors:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Note:
Accreditation Requirements
Year:
2021
Region / City:
Global
Theme:
Oncology, Breast Cancer
Document Type:
Protocol
Organization / Institution:
CAP (College of American Pathologists)
Author:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Target Audience:
Medical professionals, pathologists
Period of Validity:
From March 2022
Date of Approval:
June 2021
Date of Changes:
June 2021
Year:
2024
Region / City:
Not specified
Subject:
Pathology, Oncology
Document Type:
Protocol
Organization / Institution:
CAP (College of American Pathologists)
Author:
Uma G. Krishnamurti, MD, PhD; Kimberly H. Allison, MD; Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Target Audience:
Pathologists, Medical Institutions
Period of Validity:
March 2025
Approval Date:
Not specified
Date of Last Change:
June 2024
Version:
1.2.0.0
Protocol posting date:
March 2023
Document type:
Clinical pathology protocol
Medical field:
Breast pathology, oncology
Procedures covered:
Needle biopsy, fine needle aspiration, other biopsy procedures
Tumor types included:
Invasive breast carcinoma of any type, with or without ductal carcinoma in situ
Tumor types excluded:
Ductal carcinoma in situ without invasion, Paget disease without invasion, phyllodes tumor, lymphoma, sarcoma
Authors:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Organization:
College of American Pathologists
Accreditation status:
Recommended for clinical care, not required for accreditation
Intended use:
Reporting of biopsy specimens
Updates:
Optional reporting of largest invasive focus; revised lymphatic and/or vascular invasion terminology